From promises to policies: is big pharma delivering on transparency?
PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionAs increasing numbers of pharmaceutical companies establish policies for granting third party access to their clinical trial data, the onus shifts to those ready to begin sifting through the data
CitationDoshi, P. (2014). From promises to policies: is big pharma delivering on transparency? BMJ 2014;348:g1615. DOI: https://doi.org/10.1136/bmj.g1615
data sharing restrictions
Clinical Trials as Topic
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/6603